Following biopsy, staging of prostate cancer has had a shift from conventional CT and bone scan to the use of PSMA PET/CT, which allows differentiation of diagnosis from localised prostate cancer (if cancer confined to the prostate) to advanced prostate cancer (if spread seen to lymph nodes or other organs). Here, FOLH1 is linked to prostate carcinoma.